Hims & Hers Health (HIMS) stock declined 3% before trimming losses after Q2 GAAP loss of $0.37 per share, swinging from a year-ago profit
The telehealth company reported a GAAP loss of $0.37 per share in the second quarter, compared to a profit of $0.17 per share in the year-earlier period. Gross margins also fell to 64% from 76% year-over-year. The results were impacted by an $81 million one-time cost, including expenses related to an acquisition, restructuring, and legal reserves tied to recent litigation with the Federal Trade Commission (FTC). The FTC filed a lawsuit against Hims & Hers on July 29, alleging it shared private health data with advertisers and made subscription cancellations difficult, claims the company has vowed to fight.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
SK Hynix rose 6.78% from its previous close, currently trading at ₩1,213,000.
-
2
SK Hynix rose 8.63% from its previous close, currently trading at ₩1,234,000.
-
3
Is the Crypto Circle Legal in China? An Analysis of Legal Risks for Domestic Participants in Virtual Currency Trading
-
4
What is PAXG? An Analysis of the Investment Value of PAX Gold (PAXG)
-
5
How to Choose Among Ten Crypto Exchanges: A Comparison of Features, Custody, and Risk
-
6
What is Ethereum Push Notification Service (Push Protocol)? The Evolution of Web3 Communication Protocols
-
7
Is OKB Worth Holding Long-Term? A Comprehensive Guide to OKB Founders and Ecosystem Mechanisms
-
8
What is the Value of HON? An Analysis of the Heroes of NFT Ecosystem and Token Status
-
9
What is Adamant (ADDY)? An Overview of the Polygon Ecosystem Yield Optimizer and ADDY Token
-
10
Samsung Electronics is up 5% from its previous close, currently trading at ₩199,400.
Markets Today
Recommended Reading









